Select for export Psychedelic drugs-a new era in psychiatry? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31887/dcns.2019.21.2/dnutt PubMed 31636488 Copy citation Copy BibTeX Dialogues in Clinical Neuroscience 2019-06-29 David Nutt OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export The Potential of Psilocybin Administration in Terminal Cancer Patients Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/01.cot.0000574916.46844.cf Copy citation Copy BibTeX Oncology Times 2019-06-27 Richard Simoneaux OpenAlex Published psilocybinpsilocin DepressionAnxietyAddiction Clinical Trial More
Select for export Faces of HPPD: Hallucinogen Persisting Perception Disorder Patient Survey Results and a Descriptive Analysis of Patient Demographics, Medical Background, Drug Use History, Symptoms, and Treatments Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/adt.0000000000000178 Copy citation Copy BibTeX Addictive Disorders & Their Treatment 2019-06-09 Doreen M. Lewis OpenAlex Published psilocybin AnxietyReceptor PharmacologyEmotional Processing Observational Study More
Select for export Is Psychedelic Medicine on the Horizon? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2019.1b1 Copy citation Copy BibTeX Psychiatric News 2019-02-27 Nick Zagorski OpenAlex Published psilocybin DepressionAnxietyPTSD Review Article More
Select for export THE POTENTIAL THERAPEUTIC VALUE OF PSILOCYBIN: In Relation to Depression Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Diva portal (Dalarna University Library) 2018-12-31 Isabella Stendahl OpenAlex Published psilocybin DepressionAnxietyOCD Other More
Select for export Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2019.00672 PubMed 31572246 Copy citation Copy BibTeX Frontiers in psychiatry 2018-12-31 Hutten NRPW, Mason NL, Dolder PC, Kuypers KPC PubMed Published psilocybin DepressionAnxietyChronic Pain Randomized Controlled Trial More
Select for export Psychedelic drugs in the treatment of anxiety, depression and addiction. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.4045/tidsskr.17.1110 PubMed 30421744 Copy citation Copy BibTeX Unknown journal 2018-11-11 Kvam TM, Stewart LH, Andreassen OA. Europe PMC Published psilocybin DepressionAnxietyAddiction Animal Study More
Select for export Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/17512433.2018.1511424 PubMed 30102078 Copy citation Copy BibTeX Unknown journal 2018-08-22 Dos Santos RG, Bouso JC, Alcázar-Córcoles MÁ, Hallak JEC. Europe PMC Published psilocybin DepressionAnxietyAddiction Randomized Controlled Trial More
Select for export Psychedelics as anti-inflammatory agents. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/09540261.2018.1481827 PubMed 30102081 Copy citation Copy BibTeX International Review of Psychiatry 2018-08-12 Flanagan TW, Nichols CD. Europe PMC Published psilocybin DepressionAnxietyAddiction Review Article More
Select for export Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jad.2018.01.006 PubMed 29407543 Copy citation Copy BibTeX Journal of Affective Disorders 2018-03-31 Carrillo F, Sigman M, Fernández Slezak D, Ashton P, Fitzgerald L, Stroud J Europe PMC Published psilocybin DepressionTreatment-Resistant Depression Other More
Select for export Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD). Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acschemneuro.8b00043 PubMed 29461039 Copy citation Copy BibTeX Unknown journal 2018-02-28 Nichols DE. Europe PMC Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export „Terapia szokowa”, czyli agoniści receptor 5-HT2A w leczeniu depresji i lęku Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX CeON Repository (Centre for Evaluation in Education and Science) 2017-11-30 Joanna Stefaniuk OpenAlex Published psilocybin DepressionAnxietyPharmacology Other More
Select for export [Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges]. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/s-0043-103085 PubMed 28768346 Copy citation Copy BibTeX Unknown journal 2017-06-30 Majić T, Jungaberle H, Schmidt TT, Zeuch A, Hermle L, Gallinat J. Europe PMC Published psilocybin DepressionAnxietyPTSD Other More
Select for export Psilocybin-assisted therapy for anxiety and depression: implications for euthanasia. No abstract availability was recorded for this entry. Details DOI 10.5694/mja17.00081 PubMed 28918722 Copy citation Copy BibTeX The Medical Journal of Australia 2017-05-31 Strauss N. Europe PMC Published psilocybin DepressionAnxietyRandomized Controlled Trial Randomized Controlled Trial More
Select for export Clinical potential of psilocybin as a treatment for mental health conditions. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.9740/mhc.2017.01.024 PubMed 29955494 Copy citation Copy BibTeX Mental Health Clinician 2016-12-31 Daniel J, Haberman M. Europe PMC Published psilocybin AnxietyAddictionOCD Review Article More
Select for export Psychedelics as Medicines: An Emerging New Paradigm. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/cpt.557 PubMed 28019026 Copy citation Copy BibTeX Unknown journal 2016-12-25 Nichols DE, Johnson MW, Nichols CD. Europe PMC Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export Psilocybin for depression and anxiety associated with life-threatening illnesses. No abstract availability was recorded for this entry. Details DOI 10.1177/0269881116675771 PubMed 27909171 Copy citation Copy BibTeX Unknown journal 2016-11-30 McCorvy JD, Olsen RH, Roth BL. Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Other More
Select for export Antidepressant, Antipsychotic, and Hallucinogen Drugs for the Treatment of Psychiatric Disorders: A Convergence at the Serotonin-2A Receptor. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3928/02793695-20160616-09 PubMed 27362381 Copy citation Copy BibTeX Journal of Psychosocial Nursing and Mental Health Services 2016-06-30 Howland RH. Europe PMC Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export A Phenomenological Examination of Psilocybin and its Positive and Persisting Aftereffects Abstract available at the source but not redistributed here. Read at source. Details DOI 10.14704/nq.2016.14.2.943 Copy citation Copy BibTeX NeuroQuantology 2016-05-23 Joseph A. Zamaria OpenAlex Published psilocybin DepressionAnxietyOCD Other More
Select for export Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s2215-0366(16)30065-7 PubMed 27210031 Copy citation Copy BibTeX The Lancet Psychiatry 2016-05-16 Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M Europe PMC Published psilocybin DepressionAnxietyAddiction Other More